Hilaga, Precious Lan B.

HRN: 28-93-34  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/30/2026
AMPICILLIN 1GM (VIAL)
04/30/2026
05/02/2026
IV
2 G
Q6
PROM
Pending Pharmacy Acceptance 

 Indication:  Prophylaxis    Type of Infection:  Reproductive Tract    Compliance to guidelines: